Document Detail


Circadian gene variants in cancer.
MedLine Citation:
PMID:  24901356     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Humans as diurnal beings are active during the day and rest at night. This daily oscillation of behavior and physiology is driven by an endogenous circadian clock not environmental cues. In modern societies, changes in lifestyle have led to a frequent disruption of the endogenous circadian homeostasis leading to increased risk of various diseases including cancer. The clock is operated by the feedback loops of circadian genes and controls daily physiology by coupling cell proliferation and metabolism, DNA damage repair, and apoptosis in peripheral tissues with physical activity, energy homeostasis, immune and neuroendocrine functions at the organismal level. Recent studies have revealed that defects in circadian genes due to targeted gene ablation in animal models or single nucleotide polymorphism, deletion, deregulation and/or epigenetic silencing in humans are closely associated with increased risk of cancer. In addition, disruption of circadian rhythm can disrupt the molecular clock in peripheral tissues in the absence of circadian gene mutations. Circadian disruption has recently been recognized as an independent cancer risk factor. Further study of the mechanism of clock-controlled tumor suppression will have a significant impact on human health by improving the efficiencies of cancer prevention and treatment.
Authors:
Nicole M Kettner; Chinenye A Katchy; Loning Fu
Related Documents :
24886526 - Female breast cancer survival in qidong, china, 1972-2011: a population-based study.
25021736 - Oc-047 adenoma surveillance in the national nhs bowel cancer screening programme - is t...
24885266 - Health care needs of cancer survivors in general practice: a systematic review.
23065466 - Toll-like receptor 4 gene polymorphisms and susceptibility to bladder cancer.
16761906 - Dalteparin versus warfarin for the prevention of recurrent venous thromboembolic events...
23719766 - S-1 (teysuno(®)): a review of its use in advanced gastric cancer in non-asian populatio...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-6-5
Journal Detail:
Title:  Annals of medicine     Volume:  -     ISSN:  1365-2060     ISO Abbreviation:  Ann. Med.     Publication Date:  2014 Jun 
Date Detail:
Created Date:  2014-6-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8906388     Medline TA:  Ann Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-13     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Activation and recruitment of brown adipose tissue as anti-obesity regimens in humans.
Next Document:  Comparison of self-report and performance-based measures of everyday functioning in individuals with...